Henry Lau

998 total citations
23 papers, 820 citations indexed

About

Henry Lau is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Henry Lau has authored 23 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Hematology and 5 papers in Genetics. Recurrent topics in Henry Lau's work include Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Henry Lau is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Henry Lau collaborates with scholars based in United States, Switzerland and France. Henry Lau's co-authors include Nianhang Chen, Gondi Kumar, Robert Knight, David E. Smith, Joan H. Parks, Fredric L. Coe, Yasushi Nakagawa, Veronika Abram, J K Kawooya and Sekhar Surapaneni and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Henry Lau

23 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Lau United States 16 364 364 331 123 85 23 820
Milly E. de Jonge Netherlands 14 219 0.6× 128 0.4× 282 0.9× 99 0.8× 150 1.8× 17 867
Graham Jang United States 16 724 2.0× 111 0.3× 724 2.2× 57 0.5× 147 1.7× 26 1.5k
Christer Mattsson Sweden 24 204 0.6× 671 1.8× 90 0.3× 148 1.2× 49 0.6× 49 1.5k
Peter J. Cox United Kingdom 10 249 0.7× 71 0.2× 231 0.7× 47 0.4× 100 1.2× 12 1.1k
Cynthia M. Nijenhuis Netherlands 14 172 0.5× 113 0.3× 202 0.6× 107 0.9× 29 0.3× 28 535
Martine Hubert France 12 120 0.3× 153 0.4× 184 0.6× 80 0.7× 49 0.6× 15 591
Dennis A. Noe United States 16 333 0.9× 72 0.2× 256 0.8× 69 0.6× 46 0.5× 32 871
Oreste E. Salavaggione United States 16 468 1.3× 66 0.2× 282 0.9× 111 0.9× 137 1.6× 25 988
Olivier Grenet Switzerland 15 550 1.5× 87 0.2× 223 0.7× 56 0.5× 80 0.9× 27 1.1k
Naoaki Murao Japan 15 205 0.6× 97 0.3× 161 0.5× 21 0.2× 56 0.7× 26 624

Countries citing papers authored by Henry Lau

Since Specialization
Citations

This map shows the geographic impact of Henry Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Lau more than expected).

Fields of papers citing papers by Henry Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Lau. The network helps show where Henry Lau may publish in the future.

Co-authorship network of co-authors of Henry Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Lau. A scholar is included among the top collaborators of Henry Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Lau. Henry Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lau, Henry, et al.. (2023). Pharmacokinetics and pharmacodynamics of an oral formulation of decitabine and tetrahydrouridine. European Journal Of Haematology. 111(3). 345–355. 5 indexed citations
2.
Kasserra, Claudia, et al.. (2012). Single-dose pharmacokinetics of lenalidomide in healthy volunteers: dose proportionality, food effect, and racial sensitivity. Cancer Chemotherapy and Pharmacology. 70(5). 717–725. 32 indexed citations
3.
Chen, Nianhang, et al.. (2011). Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects. Cancer Chemotherapy and Pharmacology. 69(3). 789–797. 73 indexed citations
4.
Iida, Shinsuke, Takaaki Chou, Shinichiro Okamoto, et al.. (2010). Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma. International Journal of Hematology. 92(1). 118–126. 31 indexed citations
5.
Chen, Nianhang, et al.. (2010). Distribution of Lenalidomide Into Semen of Healthy Men After Multiple Oral Doses. The Journal of Clinical Pharmacology. 50(7). 767–774. 23 indexed citations
6.
7.
Kumar, Gondi, Henry Lau, & Oscar L. Laskin. (2008). Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction. Cancer Chemotherapy and Pharmacology. 63(6). 1171–1175. 28 indexed citations
8.
Chen, Nianhang, et al.. (2007). Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis. The Journal of Clinical Pharmacology. 47(12). 1466–1475. 202 indexed citations
9.
Lau, Henry, et al.. (2007). Pharmacokinetics of lenalidomide in subjects with various degrees of renal function. Journal of Clinical Oncology. 25(18_suppl). 2520–2520. 1 indexed citations
10.
Wang, Yanfeng, Ray Bakhtiar, James Lee, et al.. (2004). In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Biopharmaceutics & Drug Disposition. 25(2). 91–98. 15 indexed citations
11.
Zhou, Honghui, Tianling Chen, Mark T. Marino, et al.. (2000). Population PK and PK/PD modelling of microencapsulated octreotide acetate in healthy subjects. British Journal of Clinical Pharmacology. 50(6). 543–552. 9 indexed citations
12.
Zhou, Honghui, Henry Lau, Elisabeth G.E. de Vries, et al.. (2000). Population Pharmacokinetics/Toxicodynamics (PK/TD) Relationship of SAM486A in Phase I Studies in Patients with Advanced Cancers. The Journal of Clinical Pharmacology. 40(3). 275–283. 25 indexed citations
13.
Zhou, Honghui, Henry Lau, M. Guerret, et al.. (1999). Effect of Meal Timing Not Critical for the Pharmacokinetics of Tegaserod (HTF 919). The Journal of Clinical Pharmacology. 39(9). 911–919. 27 indexed citations
14.
McLeod, James F., et al.. (1999). Pharmacokinetics (PK) of SDZ HTF 919 (HTF) not altered in subjects with severe renal insufficiency requiring hemodialysis. Clinical Pharmacology & Therapeutics. 65(2). 203–203. 10 indexed citations
15.
Berenson, James R., Lee S. Rosen, Robert Vescio, et al.. (1997). Pharmacokinetics of Pamidronate Disodium in Patients with Cancer with Normal or Impaired Renal Function. The Journal of Clinical Pharmacology. 37(4). 285–290. 80 indexed citations
16.
Dressman, Jennifer, Rosemary R. Berardi, Grace H. Elta, et al.. (1992). Absorption of Flurbiprofen in the Fed and Fasted States. Pharmaceutical Research. 9(7). 901–907. 32 indexed citations
17.
Fleishaker, Joseph C., J. Paul Phillips, & Henry Lau. (1990). Effect of food on the bioavailability of adinazolam from a sustained release formulation: Effect of meal timing and lack of dose dumping. Biopharmaceutics & Drug Disposition. 11(8). 715–727. 6 indexed citations
18.
Smith, David E. & Henry Lau. (1983). Determinants of bumetanide response in the dog: Effect of probenecid. Journal of Pharmacokinetics and Biopharmaceutics. 11(1). 31–46. 15 indexed citations
19.
Smith, David E. & Henry Lau. (1983). Determinants of Bumetanide Response in the Dog: Effect of Indomethacin. Journal of Pharmaceutical Sciences. 72(11). 1298–1302. 6 indexed citations
20.
Lau, Henry, Li‐Jane Shih, & David E. Smith. (1983). Effect of probenecid on the dose-response relationship of bumetanide at steady state.. Journal of Pharmacology and Experimental Therapeutics. 227(1). 51–54. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milly E. de Jonge Breakdown of academic impact, for papers by Graham Jang Breakdown of academic impact, for papers by Christer Mattsson Breakdown of academic impact, for papers by Peter J. Cox Breakdown of academic impact, for papers by Cynthia M. Nijenhuis Breakdown of academic impact, for papers by Martine Hubert Breakdown of academic impact, for papers by Dennis A. Noe Breakdown of academic impact, for papers by Oreste E. Salavaggione Breakdown of academic impact, for papers by Olivier Grenet Breakdown of academic impact, for papers by Naoaki Murao
Rankless by CCL
2026